Efficacy of Stool Testing for Colorectal Cancer Screening Update
This online activity is designed to help primary care physicians and other providers better understand the options for colorectal cancer screening and increase confidence in the use of FOBT/FIT as an effective screening modality. The activity provides
a review of the current United States Preventive Services Task Force (USPSTF) guidelines for colorectal cancer screening (including the change to begin screening at age 45) and discusses the options for colorectal cancer screening and the efficacy
of stool-based testing for increasing overall screening rates. The science behind fecal occult blood tests (FOBT) and fecal immunochemical tests (FIT), including the differences between the tests and general information on their sensitivity and specificity
in detecting colorectal cancer, is discussed. Valuable insights regarding the challenges associated with implementation of a stool-based testing program are shared along with national and state resources designed to help providers to implement a comprehensive,
high-quality colorectal cancer screening program.
Intended Audience
This course is intended for physicians, nurse practitioners, physician assistants, nurses, and leaders in public health.
Learning Objectives
Upon completion of this activity, learners
should be able to:
- Identify colorectal cancer screening options for average-risk patients according to clinical guidelines
- Describe the differences in guaiac-based FOBT and FIT in terms of sensitivity and specificity, as well as diet and medication restrictions
- Recognize the efficacy of FOBT/FIT in finding colorectal cancer and lowering overall mortality due to colorectal cancer.
- Assess the benefits of offering a choice of colorectal cancer screening tests to patients.
- Examine common barriers to implementation of FOBT/FIT and recognize tools and methods to overcome them.
- Utilize resources available to assist primary care physicians in the implementation of a stool-based screening program.
Faculty
Deana Baptiste, PhD, MPH
Senior Director, Guideline
Development, American Cancer Society
Deana Baptiste is an Epidemiologist and the Senior Director of Cancer Screening Guideline Development at the American Cancer Society (ACS). Currently, she serves as the methodologist and leads the development process for the ACS evidence-based cancer
screening guidelines. Additionally, she provides subject matter expertise and support for the Society’s cancer screening, prevention, and control initiatives. She is also an adjunct professor at the Morehouse School of Medicine, Public Health Program
where she lectures on topics in epidemiology and cancer prevention and control.
Before joining the ACS in 2023, Dr. Baptiste served in the US Public Health Service Commissioned Corp as an Epidemiologist at the Centers for Disease Control and Prevention. Her previous work included research and managing federal programs through cooperative
agreements with state and local public health partners, for environmental hazard assessments, cancer cluster investigations, and various epidemic outbreak investigations.
Course Fees
Massachusetts Medical Society (MMS) Physician Member: Free
MMS Resident/Student Member: Free
Non-Member Physician: Free
Non-Members Resident/Student: Free
Allied Health Professional/Other: Free
This webinar was supported by the Centers for Disease Control and Prevention (CDC) Cooperative Agreement 1 NU58DP006271-01-00. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the CDC.
Format and Estimated Time to Complete: Video recording & slides/1 hour & 20 minutes
Accreditation and Credit Information
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing
Medical Education (ACCME) through the joint providership of the Massachusetts Medical Society and the Massachusetts Department of Public Health. The Massachusetts Medical Society is accredited by the ACCME to provide continuing medical education for physicians.
AMA Credit Designation Statement
The Massachusetts Medical Society designates this enduring material for a maximum of 1.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent
of their participation in the activity.
This activity meets the criteria of the Massachusetts Board of Registration in Medicine for risk management study.
National Commission on Certification of Physician Assistants (NCCPA)
Physician Assistants may claim 1.25 Category 1 credits for completing this activity. NCCPA accepts
AMA PRA Category 1 Credit(s)™ from organizations accredited by ACCME or a recognized state medical society.
Exam /Assessment: A score of 70% or higher is required to receive
AMA PRA Category 1 Credit(s)™.
Activity Term
Original Release Date: May 7, 2024
Review Date: N/A
Termination Date: May 7, 2027
System Requirements
Desktops/Laptops
Windows 10
Mac OSX 10.6 higher
Most modern browsers including:
IE 11+
Firefox 18.0+
Chrome latest version
Safari 12+
Mobile/Tablet
iOS devices beginning with OS version 10 or higher (includes, iPhone, ipad and iTouch devices)
